Dalgan side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Dalgan. Common side effects include angioedema among females and alopecia among males.

The phase IV clinical study is created by eHealthMe based on 9 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jul, 07, 2022

9 people who take Dalgan and have side effects are studied.


What is Dalgan?

Dalgan has active ingredients of dezocine. eHealthMe is studying from 11 Dalgan users for its effectiveness, alternative drugs and more.

Number of Dalgan reports submitted per year:

Dalgan side effects.

Dalgan side effects by gender *:

female:

  1. Angioedema (rapid swelling of the dermis)
  2. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  3. Drug ineffective

male:

  1. Alopecia (absence of hair from areas of the body)
  2. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)

Dalgan side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

  1. Alopecia (absence of hair from areas of the body)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)

60+:

  1. Drug ineffective

* Approximation only. Some reports may have incomplete information.

Do you take Dalgan?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on dezocine (the active ingredients of Dalgan) and Dalgan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Dalgan:

All Dalgan side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: